Human Fibronectin Platinum ELISA

Description: The human Fibronectin ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Fibronectin. The human Fibronectin ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Fibronectin is an ubiquitous extracellular glycoprotein that exists in a soluble form in body fluids and in an insoluble form in the extracellular matrix.
It plays a major role in many important physiological processes, such as embryogenesis, wound healing, hemostasis and thrombosis.

Fibronectin is secreted as a dimer with a monomer molecular weight of 220-250 kDa. Fibronectin is composed of three types of modules organized into functional domains that are resistant to proteolysis and contain binding sites for extracellular matrix proteins, cell surface receptors and circulating blood proteins.

In general, fibronectin is synthesized by and present around fibroblasts, endothelial cells, chondrocytes, glial cells, and myocytes. Fibronectin is abundant in the connective tissue matrix and in basement membranes. Extremely high levels of the glycoprotein are found in plasma. Fibronectin has been reported to play a major role in the cardiovascular system, being functionally involved in blood clotting, atherosclerosis, hypertension and myocardial infarction.

Fibronectin's importance during cancer progression has further been shown. It represents an active element in the process of T cell activation in the immune cascade triggered by organ transplantation. Fetal fibronectin has been described as a predictor of term lab.

Citations: Torricelli,P.; Fini,M.; Giavaresi,G.; Carpi,A.; Nicolini,A.; Giardino,R.. Effects of systemic glucocorticoid administration on tenocytes. Biomedicine & Pharmacotherapy 2006;60:380-385. (Link)

References: Patard,J.J.; Saint,F.; Velotti,F.; Abbou,C.C.; Chopin,D.K.. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol.Res. 1998;26:155-159. (Link)

Labat-Robert,J.. Fibronectin in malignancy. Semin.Cancer Biol. 2002;12:187-195. (Link)

Knowlton,A.A.; Connelly,C.M.; Romo,G.M.; Mamuya,W.; Apstein,C.S.; Brecher,P.. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J.Clin.Invest 1992;89:1060-1068. (Link)

Himeno,H.; Crawford,D.C.; Hosoi,M.; Chobanian,A.V.; Brecher,P.. Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994;23:823-826. (Link)

Ross,R.. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809. (Link)

Corbett,S.A.; Wilson,C.L.; Schwarzbauer,J.E.. Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. Blood 1996;88:158-166. (Link)

Magnusson,M.K.; Mosher,D.F.. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler.Thromb.Vasc.Biol. 1998;18:1363-1370. (Link)

Coito,A.J.; de,Sousa M.; Kupiec-Weglinski,J.W.. Fibronectin in immune responses in organ transplant recipients 28. Dev.Immunol. 2000;7:239-248. (Link)

Labat-Robert,J.; Szendroi,M.; Godeau,G.; Robert,L.. Comparative distribution patterns of type I and III collagens and fibronectin in human arteriosclerotic aorta. Pathol.Biol.(Paris) 1985;33:261-265. (Link)

Akiyama,S.K.; Yamada,S.S.; Chen,W.T.; Yamada,K.M.. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J.Cell Biol. 1989;109:863-875. (Link)

Chernousov,M.A.; Fogerty,F.J.; Koteliansky,V.E.; Mosher,D.F.. Role of the I-9 and III-1 modules of fibronectin in formation of an extracellular fibronectin matrix. J.Biol.Chem. 1991;266:10851-10858. (Link)

Sottile,J.; Schwarzbauer,J.; Selegue,J.; Mosher,D.F.. Five type I modules of fibronectin form a functional unit that binds to fibroblasts and Staphylococcus aureus. J.Biol.Chem. 1991;266:12840-12843. (Link)

Vandenbroeck,K.; Alloza,I.; Gadina,M.; Matthys,P.. Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J.Pharm.Pharmacol. 2004;56:145-160. (Link)

Emri,S.; Ustundag,Y.; Budak,T.; Karakoca,Y.; Ozdemir,O.. Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma. Monaldi Arch.Chest Dis. 1997;52:335-338. (Link)

Kiss,H.; Ahner,R.; Hohlagschwandtner,M.; Leitich,H.; Husslein,P.. Fetal fibronectin as a predictor of term labor: a literature review. Acta Obstet.Gynecol.Scand. 2000;79:3-7. (Link)